Legend Biotech Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LEGN | LYEL | CGEM | GMAB | IDYA | RCUS | |
|---|---|---|---|---|---|---|
| Market cap | 3.46B | 202.66M | 918.80M | 22.98B | 3.48B | 3.06B |
| P/E (TTM) | — | — | — | 29.4 | — | — |
| Forward P/E | 17.0 | -1.3 | -5.9 | 24.5 | -9.0 | -7.5 |
| Price/book | 2.8 | 0.8 | 3.0 | 3.7 | 2.9 | 6.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −43.32% | −48.25% | +98.34% | +13.43% | +34.89% | +46.69% |
| Today | −4.40% | −5.05% | −3.73% | +0.81% | −0.14% | −0.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LEGN news ›Legend Biotech: New Myeloma, Lymphoma CAR-T Data at ASH
Topline data: In triple-class–exposed multiple myeloma patients with three prior lines of therapy from CARTITUDE-1, a single infusion of ciltacabtagene autoleucel (CARVYKTI) delivered a median progression-free survival (mPFS) of 50.4…
Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says
Legend Biotech's multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' anito-cel approaches a potential approval and Johnson & Johnson's Tec-Dara gains... Biotechnology & Medical Research Legend…
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
A former CEO of a cancer-detection company joins Alamar's board. Stock Titan - Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team Alamar Biosciences (ALMR) appointed former GRAIL CEO Bob…
Legend Biotech Corp (LEGN) Director Sanders Corazon (Corsee) D.
Sanders Corazon (Corsee) D., a Director at Legend Biotech Corp LEGN, disclosed a sale of 27,370 shares of the company on 2026-09-29, according to a recent SEC Filing. Following the transaction, the insider owns 52,731 shares of the…
Legend Biotech Director Corazon Sanders Sells 27,370 Shares at $9.46 Average Price
Pale Fire Capital Reports 5.1% Ownership Stake in Lightspeed Commerce Forbion Entities Reveal 5.1% Stake in Aura Biosciences via SEC Filing A Form 4 filing with the SEC dated October 1, 2026, reveals that Corazon (Corsee) D. Sanders, a…
Josh Schwartz Joins Legend Biotech as Senior Vice President
Legend Biotech, a global biotechnology company based in New Jersey, has hired Josh Schwartz, MD, MBA as Senior Vice President. Legend develops advanced cell therapies across several technology platforms, including autologous and allogeneic…
Munster statement: CEO to step down
NEWS: Munster have confirmed that chief executive Ian Flanagan will leave his position at the end of October, bringing his six-year tenure at the Irish province to a close. Flanagan, who was appointed CEO in 2019, informed the Munster…
HC Wainwright & Co. reiterates Buy rating on Legend Biotech, $65 price target
HC Wainwright & Co. reiterated their Buy rating on Legend Biotech's stock with a price target of $65.00. The price target implies an upside of 245.4% from the Sep 29 close of $18.82. Key takeaways from the analyst note Strong Long-Term…
Ivan Chen named CEO of BandLab Technologies as co-founder Meng Ru Kuok transitions to Executive Chairman
BandLab Technologies has named Ivan Chen as its new Chief Executive Officer. Chen takes the role on Thursday (October 1), with co-founder Meng Ru Kuok becoming Executive Chairman. The company says Kuok has served as Chairman and CEO since…
Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion
Five-year overall survival rate was 69.2%, adding to growing long-term evidence supporting the curative potential of CARVYKTI in earlier-line RRMM “These five-year data, showing that 50% of patients remained alive and progression-free…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com2
-
biobuzz.io1
-
firstwordpharma.com1
-
freedom959.net1
-
globenewswire.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.